Tag Archives: MARA

Post navigation

Our first order of business this morning is to review the recent performance of ECYT, which we initially slated for observation in our report on February 28th. At the time, the stock had been slowly gaining momentum for much of February, and it looked ripe for a more pronounced breakout.

That day, as the stock was trading for as little as 4.51, we witnessed an explosion in volume that has precipitated a very impressive run, persisting for over two weeks up to the present time. Yesterday’s session brought a new high of 11.54 in ECYT, which marks an upswing of 156% in a relatively short time frame.

Valeant Pharma International, Inc. VRX

On Monday morning, we came up with some options ideas for VRX, which we noted was “ready for a bottom bounce”. We also made reference to a huge Form-4 buy of $108.8M came in as well, which led us to postulate that “for now the stock has gone as low as it’s going to go.”

We couldn’t have been any more spot-on in our assessment of VRX, and the result has been a solid performance for the short-term calls we put on watch, the VRX Weekly $15 & $15.50 Calls. The $15′s ran from .65-1.15 for a gain of 77%, while the $15.50′s moved from a low of .30 to .71, an increase of 137%

We had some longer-term ideas as well which we will likely come back to in an upcoming report, as it appears VRX will continue to head up. On that note, we’ll also look to roll up our strike prices on the weekly calls to the $16 & $16.50′s.

Even though much of our focus over the past couple of years has turned to short term options trading, penny stocks have always been our bread and butter, and RXMD is an example of one that we’ve found incredible success with of late.

After appearing in our morning reports every single day this week as it streaked into blue skies, RXMD once again registered a new 5-year high of .213 yesterday. From Monday’s low of .1171 it marked an intraweek upswing of 82%

As we’ve mentioned several times now, we had the chance to get into RXMD as low as .0663 following our initial alert on February 22nd, and from that point, yesterday’s high represented an increase of 221% over a period of eleven trading days.

__________

Rennova Health, Inc. RNVA

Also in the penny stock arena, we did well with RNVA this week, including it in Tuesday’s premarket report. From a subpenny low of .006, the stock made a 200% move to yesterday’s high of .018, and it’s gone even higher in the premarket this morning.

Zosano Pharma Corp. ZSAN

After tagging ZSAN as a bottom-bounce play on Friday, at which time is was trading for as little as 6.8175, we’ve witnessed an explosion this week. This play has also appeared in three out of our last five reports as it has absolutely taken off.

Yesterday morning, we pointed out that despite already making significant gains, if it broke an area of key resistance we highlighted on the chart, that things could get interesting and they certainly did.

ZSAN exploded from a low of 12.57 and ran as high as 25.70, an intraday move of 104% an a mind-bending 275% over a period of just a few days. That’s fantastic for a stock that started out above six dollars!

Fresh Options Idea: SPY Weekly $274.50-277 Calls*

*Do NOT trade weekly calls on a Friday unless you are an expert level trader!

We’ve talked about RXMD every day this week, because the stock has continued to streak to new highs each day. As we’ve mentioned, our February 22nd alert on RXMD enabled our readers to gain entry for as little as .0663.

Yesterday, our tenth session tracking this play, the stock soared to a new five year high of .197, registering as a total increase from our observed low amounting to 197%

__________

Zosano Pharma Corp. ZSAN

We put ZSAN back on our radars as a bottom-bounce play on Friday, and witnessed a subsequent low of 6.8175. From that point, the stock has made a very nice move in just a short time.

Yesterday, following yet another tag in our premarket report, ZSAN ran from 9.58 to 15.74. That worked out to an intraday rise of 64% and a total increase of 131% in a matter of just four trading days.

As you can see on the included chart snapshot, if the stock can pass through the highlighted resistance area and breach the 200DMA, things could get very interesting.

Dollar Tree, Inc. DLTR

We formulated a bearish options idea for Dollar Tree yesterday morning, and it worked out in our favor as the stock gapped down hard, followed by more backsliding during the session. Our targets were the DLTR Weekly $95-92 Puts and the two sets of contracts in the lower end of that range yielded notable intraday gain opportunities.

Yesterday we noted that TJX was exhibiting some interesting premarket activity despite missing EPS estimates on its Q4 earnings call. We also mentioned that we’d look for the very common dip-and-rip scenario, which occurred on cue.

Our options targets were the TJX 03/16 $80-85 Calls, and unsurprisingly, we got considerable gain opportunities out of all three sets of contracts in that range:

Yesterday morning, we took the initiative to tag ECYT in our premarket report for the first time since November. The stock had already been steadily rising for a few weeks despite the reporting of Q4 losses, and the company revealed the pricing of a public offering at 4.20/share.

That helped to bring the biggest single session upswing for the stock since October, with ECYT running from a low of 4.51 up to 6.08. It was good for a highly respectable 35% increase, and sufficient to have the stock claim the title of top NASDAQ gainer of the day.

Ford is the first of a couple of bottom-watch plays we want to signal for observation as we kick off a fresh trading week. The month of January was rough for the Detroit automaker, bringing a precipitous fall into heavily oversold territory.

We are just now, in February, beginning to see the signs of a recovery. As you can see on the snapshot of the chart below, the stock has just started to come off of being oversold and bounce off of its lowest PPS since August. The MACD also appears to be converging for an upcoming cross, and there’s a gap to the upside as well.

We’ll look to take advantage of this setup by tracking the F 03/02 10.37-11.37 Calls in the days and weeks ahead.

BioMarin Pharmaceutical, Inc. BMRN

Another potential bottom play we want to look at this morning is BMRN, which also recently has been beaten down to what we feel are unsustainable low levels. We’re getting a heavy multiple-bottom signal as the strength index is tumbling toward extremely oversold territory.

The look of the MACD suggests some further decrease or sideways trading could occur, which is why we’ll want to look at a set of extended term options contracts, the BMRN 03/16 $80 & 85 Calls. With over a month until expiration, that should give us ample time for the stock to realize the recovery it appears to be building toward.

Blue Horseshoe Stocks BuzzCloud

Attention Readers:

Blue Horseshoe Stocks is part of the Bull in Advantage Network.

Our picks are selected independently by our staff, and in most instances we do not receive compensation for the coverage. We are, however, active stock traders, thus it should be assumed that we are trading any/all stocks mentioned. In the rare event that we are paid either by the company, or a third-party, it is immediately made public via our Disclaimer. No exceptions.

PLEASE NOTE: BY ACCESSING, BROWSING, OR USING THIS SITE, YOU AGREE TO BE BOUND BY ALL TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. NO EXCEPTIONS.